ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,174 | +17.1% | 16,846 | +13.6% | 0.00% | – |
Q2 2023 | $294,712 | +19.9% | 14,832 | +3.3% | 0.00% | – |
Q1 2023 | $245,850 | -11.9% | 14,352 | +0.6% | 0.00% | – |
Q4 2022 | $279,126 | +42.4% | 14,263 | +15.9% | 0.00% | – |
Q3 2022 | $196,000 | +21.7% | 12,308 | +5.6% | 0.00% | – |
Q2 2022 | $161,000 | +22.9% | 11,651 | +41.0% | 0.00% | – |
Q1 2022 | $131,000 | -28.0% | 8,261 | -0.3% | 0.00% | – |
Q4 2021 | $182,000 | -29.7% | 8,290 | -4.0% | 0.00% | – |
Q3 2021 | $259,000 | -29.6% | 8,637 | +4.1% | 0.00% | – |
Q2 2021 | $368,000 | +8.9% | 8,297 | +8.5% | 0.00% | – |
Q1 2021 | $338,000 | -27.8% | 7,646 | -10.6% | 0.00% | – |
Q4 2020 | $468,000 | +127.2% | 8,551 | -4.8% | 0.00% | – |
Q3 2020 | $206,000 | +9.6% | 8,980 | 0.0% | 0.00% | – |
Q2 2020 | $188,000 | +40.3% | 8,980 | -6.5% | 0.00% | – |
Q1 2020 | $134,000 | – | 9,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |